AMPAR
AMPAR is an glutamate ionotropic α-amino-3-hydroxy- 5-methylisoxazole-4-propionic acid receptor that mediates fast excitatory synaptic transmission in the central nervous system.
Products Related to AMPAR(55)
- GC10275DNQX disodium saltCAS: 1312992-24-7Purity: >95.00%
DNQX disodium salt is a competitive, non-NMDA glutamate receptor antagonist, with IC 50 values of 0.5, 2, and 40μM for AMPA, kainite, and NMDA receptors, respectively.
- GC11259GYKI 47261 dihydrochlorideCAS: 220445-20-5Purity: >98%
AMPA receptor antagonist, non-competitive and selective
- GC11301GYKI 52466 dihydrochlorideCAS: 102771-26-6Purity: >98%
GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively.
- GC12589CP 465022 hydrochlorideCAS: 199655-36-2Purity: >98%
AMPA receptor antagonist, non-competitive and selective
- GC12703Philanthotoxin 74CAS: 1227301-51-0Purity: >98.00%
Philanthotoxin 74 (PhTx 74) is an AMPAR antagonist; inhibits GluR3 and GluR1 with IC50s of 263 and 296 nM, respectively.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC17695 | Aniracetam | 72432-10-1 | >99.50% | |
Nootropic drug for senile dementia | ||||
| GC10270 | Noopept | 157115-85-0 | >99.50% | |
An Analytical Reference Standard | ||||
| GC10272 | pep2-SVKI | 328944-75-8 | >98% | |
Inhibitor peptide corresponding to last 10 amino acids of the C-terminus of the GluR2 subunit | ||||
| GC10275 | DNQX disodium salt | 1312992-24-7 | >95.00% | |
DNQX disodium salt is a competitive, non-NMDA glutamate receptor antagonist, with IC 50 values of 0.5, 2, and 40μM for AMPA, kainite, and NMDA receptors, respectively. | ||||
| GC10415 | Tezampanel | 154652-83-2 | >98% | |
AMPA receptor antagonist | ||||
| GC10551 | pep4c | 243843-43-8 | >98% | |
Inactive control peptide analog of pep2m | ||||
| GC10669 | pep2-EVKI | 1315378-67-6 | >98% | |
Inhibitor peptide that selectively disrupts binding of the GluR2 subunit(at the C-terminal PDZ site) to PICK1 | ||||
| GC11071 | (R)-AMPA | 83654-13-1 | >98% | |
inactive enantiomer of AMPA | ||||
| GC11244 | pep2-AVKI | 1315378-69-8 | >98% | |
Inhibitor peptide that selectively disrupts binding of the GluR2 subunit(at the C-terminal PDZ site) to PICK1 | ||||
| GC11259 | GYKI 47261 dihydrochloride | 220445-20-5 | >98% | |
AMPA receptor antagonist, non-competitive and selective | ||||
| GC11301 | GYKI 52466 dihydrochloride | 102771-26-6 | >98% | |
GYKI 52466 dihydrochloride is an orally active, highly selective and noncompetitive AMPA/kainate receptor antagonist with the IC50 values of 7.5 and 11μM, respectively. | ||||
| GC11397 | UBP 282 | 544697-47-4 | >98% | |
AMPA and kainate receptor antagonist | ||||
| GC11598 | Diazoxide | 364-98-7 | >99.50% | |
positive allosteric modulator of the AMPA and kainate receptors | ||||
| GC11799 | CNQX | 115066-14-3 | >98.00% | |
CNQX is an effective competitive antagonist of AMPA/kainate receptors, with IC50 values of 0.3µM and 1.5µM, respectively[1]. | ||||
| GC11889 | (S)-(-)-5-Fluorowillardiine | 140187-23-1 | >95.00% | |
AMPA receptor agonist | ||||
| GC12207 | Cyclothiazide | 2259-96-3 | >98.50% | |
positive allosteric modulator of AMPA receptors | ||||
| GC12589 | CP 465022 hydrochloride | 199655-36-2 | >98% | |
AMPA receptor antagonist, non-competitive and selective | ||||
| GC12703 | Philanthotoxin 74 | 1227301-51-0 | >98.00% | |
Philanthotoxin 74 (PhTx 74) is an AMPAR antagonist; inhibits GluR3 and GluR1 with IC50s of 263 and 296 nM, respectively. | ||||
| GC12742 | CP-465022 (maleate) | 199656-46-7 | >98% | |
AMPA antagonist | ||||
| GC12863 | 1-BCP | 34023-62-6 | >98% | |
potentiator of AMPA-mediated responses | ||||
| GC12999 | Pep1-AGL | - | >98% | |
Analog of Pep1-TGL | ||||
| GC13007 | PEPA | 141286-78-4 | >99.50% | |
Novel allosteric potentiator of AMPA receptor desensitization | ||||
| GC13032 | (RS)-AMPA hydrobromide | 171259-81-7 | ≥99.00% | |
AMPAR agonist | ||||
| GC13164 | Ampalex | 154235-83-3 | >99.50% | |
An AMPA receptor modulator | ||||
